skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

Sareum Holdings [LON:SAR] is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of autoimmune diseases and cancer. Sareum Holdings aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.

Since COVID19, the company has been looking at how its small molecule inhibitors could be used in severe cases of the coronavirus

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Back To Top